Skip to main content
. 2018 Mar 1;8:18. doi: 10.1186/s13550-018-0373-9

Fig. 4.

Fig. 4

Specific concentration (as a percentage of injected activity) for lesions (for each site of disease) and the main organs at risk 1, 4 and 24 h after administration